SCHEMBL2312129

SCHEMBL2312129

CC(=O)Nc1ccc(S(C)(=O)=O)c(Cl)c1

nearest known ligand 0.69

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.69
ATAD2 Q6PL18 1/20 0.54
CECR2 Q9BXF3 1/20 0.54
PIK3CD O00329 1/20 0.52
PIK3CA P42336 1/20 0.52
PIK3CB P42338 1/20 0.52
PIK3CG P48736 1/20 0.52
RORC P51449 5/20 0.51
CDK1 P06493 1/20 0.51
IDO1 P14902 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ATM Q13315 1/20 0.48
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6108064 0.87 ATAD2 (0.65) ALDH1A1ATAD2CECR2RORCCDK1
SCHEMBL8859942 0.85 HSD11B1 (0.56) ALDH1A1PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL6514545 0.85 CA2 (0.56) ALDH1A1ATAD2CECR2RORCCDK1
SCHEMBL2314802 0.83 ALDH1A1 (0.51) ALDH1A1ATAD2CECR2RORCCDK1
SCHEMBL15545274 0.81 MEN1 (0.55) ALDH1A1ATAD2CECR2RORCCDK1
SCHEMBL2318661 0.81 ALDH1A1 (1.00) ALDH1A1CDK1IDO1SMN1; SMN2MEN1
SCHEMBL27213996 0.81 ALDH1A1 (0.47) ALDH1A1IDO1MEN1MAPTKMT2A
SCHEMBL30712531 0.81 ALDH1A1 (0.47) ALDH1A1IDO1MEN1MAPTKMT2A
SCHEMBL6815605 0.80 F13A1 (0.47) ALDH1A1RORCMEN1KMT2A
SCHEMBL2317327 0.80 ALDH1A1 (0.69) ALDH1A1PIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642640-B2 1-phenylpyrrole derivatives EXELIXIS, INC. (US) 2014-02-04 US disclosed
US-8642640-B2 1-phenylpyrrole derivatives EXELIXIS, INC. (US) 2014-02-04 US disclosed
US-8642640-B2 1-phenylpyrrole derivatives EXELIXIS, INC. (US) 2014-02-04 US disclosed
EP-2349996-B1 1-PHENYLPYRROLE COMPOUNDS EXELIXIS INC (US) 2014-01-01 EP disclosed
EP-2349996-B1 1-PHENYLPYRROLE COMPOUNDS EXELIXIS INC (US) 2014-01-01 EP disclosed
US-20110263544-A1 1-Phenylpyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US disclosed
US-20110263544-A1 1-Phenylpyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US disclosed
US-20110263544-A1 1-Phenylpyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US disclosed
CN-102177137-A 1-phenylpyrrole compounds EXELIXIS INC 2011-09-07 CN disclosed
EP-2349996-A1 1-PHENYLPYRROLE COMPOUNDS Exelixis, Inc. (US) 2011-08-03 EP disclosed
WO-2010042626-A1 1-PHENYLPYRROLE COMPOUNDS EXELIXIS, INC. (US) 2010-04-15 WO disclosed
WO-2010042626-A1 1-PHENYLPYRROLE COMPOUNDS EXELIXIS, INC. (US) 2010-04-15 WO disclosed
US-5106960-A Fiber-reactive and monoazo red and yellow dyes; color- and washfastness; formaldehyde-resistance; brightness CIBA-GEIGY CORPORATION (US) 1992-04-21 US disclosed
EP-0039306-B1 AZO DYESTUFFS, METHODS FOR THEIR PREPARATION AND THEIR USE CIBA-GEIGY AG (CH) 1984-01-11 EP disclosed
EP-0039306-A1 Azo dyestuffs, methods for their preparation and their use CIBA-GEIGY AG (CH) 1981-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263544-A1 1-Phenylpyrrole Derivatives REN, AGTR1, NR3C2 ALDH1A1 252/4885ATAD2 4203/4885CECR2 1843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.